Breaking
Friday, June 19, 2026

Drug Approvals Analysis

🌏 NMPA

Expert commentary and market intelligence for pharma strategy teams

Showing 1–12 of 27 articles

High impact AnalysisJun 9, 2026

Drug Discovery Technology Market Size Tops USD 80.27 Billion by 2035

5 min

Dr. Yuki Tanaka
High impact AnalysisJun 9, 2026

Clinical Trials Outsourcing Market Size: 2026-2034 Growth Outlook

5 min

Dr. Yuki Tanaka
High impact AnalysisJun 6, 2026

ASCO26: Revolution's Daraxonrasib Phase III Data Reshapes Pancreatic Cancer Odds

oncology · 7 min

Dr. Yuki Tanaka
High impact AnalysisJun 3, 2026

Kelun-Biotech Secures New Drug Approval for SKB118: Investor and BD Guide

FDA · oncology · 5 min

Dr. Yuki Tanaka
High impact AnalysisJun 3, 2026

AbbVie Secures FDA Approval for ImmunoGen's Elahere

FDA · rare blood cancers · 6 min

Dr. Yuki Tanaka
High impact AnalysisJun 2, 2026

Shionogi's Xocova Gains FDA Clearance for COVID-19 Post-Exposure Prevention

FDA · COVID-19 · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

UCB's Bimzelx Triumph: Psoriatic Arthritis Market Implications and Competitive Landscape

FDA · psoriatic arthritis · 8 min

Dr. Yuki Tanaka
High impact AnalysisJun 2, 2026

CDER Leadership Changes: Navigating the Impact on Pharmaceutical Strategy

FDA · 11 min

Dr. Yuki Tanaka
High impact AnalysisJun 2, 2026

Rusan Pharma Secures PMDA GMP Approval, Boosting Global Market Access

PMDA · 8 min

Dr. Yuki Tanaka
Medium impact AnalysisJun 1, 2026

Merck's Phase 3 Program: Addressing the Gaps

3 min

Dr. Sarah Mitchell
Medium impact AnalysisJun 1, 2026

GlycoNex Secures PMDA Approval for GNX1021 Phase I Trial

PMDA · 3 min

Dr. Yuki Tanaka
Medium impact AnalysisMay 30, 2026

MannKind's Pediatric Expansion: A New Era for Afrezza

diabetes · 3 min

Dr. Yuki Tanaka